MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE
批准号:
8172391
负责人:
Arash Grakoui
金额:
$4.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30
关键词:
AcuteAntigen-Presenting CellsAntiviral ResponseApoptosisBiological ModelsCD moleculeCD4 Positive T LymphocytesCD8B1 geneCellsChronic Hepatitis CComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentEpitopesEquilibriumFailureFibrosisFundingGrantHepatic Stellate CellHepatitisHepatitis C virusIL7R geneImmuneImmune TargetingImmune responseIndividualInfectionInstitutionManuscriptsMediator of activation proteinMolecularMusOutcomePhenotypeResearchResearch PersonnelResourcesSourceT-LymphocyteTretinoinUnited States National Institutes of HealthViralViruscell typeexhaustintrahepaticresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
We hypothesized that interaction between CD4+ T cells and professional antigen presenting cells (APCs) is insufficient in HCV infected individuals, and that the resultant failure to generate and maintain a robust CD4+ T helper response contributes to viral persistence through alteration of the CD8+ T cell effector response.
We successfully characterized the phenotype of HCV specific T cells and found the cells expressed high levels of PD-1 and low levels of CD127, an exhausted phenotype correlating with poor effector function. These cells are also uniquely susceptible to apoptosis.
Recently we showed that these cells co-express the costimulatory molecule CD 86 during acute infection but rapidly lose this expression with the transition to viral persistence. This suggested that the balance between co-stimulatory and co-inhibitory molecules early in infection may influence infection outcome. We identified a complete panel of HCV epitopes to which HCV specific T cells should respond which will now allow for identification of specific immune deficits that may be targets for immune augmentation.
Together, these studies have helped unravel the interplay between the APC and the T cell and elucidate mechanistic failures in the antiviral response. We recently submitted two manuscripts showing, in our murine model systems, that intrahepatic APC and specifically, hepatic stellate cells (HSC) are critical mediators of the intrahepatic immune response. HSC are the cell type responsible for fibrosis in chronic HCV infection; however, we recently showed that in the presence of TGFb, and in a retinoic acid-dependent manner, they contribute to the development of Tregulatory cells. We continue to dissect the molecular mechanisms responsible for these important observations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Correlates of protective immunity to HCV and rational vaccine design
-
批准号:10393614
-
项目类别:
-
资助金额:$204.03万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
-
批准号:10393615
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design
-
批准号:10205764
-
项目类别:
-
资助金额:$201.88万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
-
批准号:10205768
-
项目类别:
-
资助金额:$73.75万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
-
批准号:10393618
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
-
批准号:10608110
-
项目类别:
-
资助金额:$79.13万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design
-
批准号:10608105
-
项目类别:
-
资助金额:$205.42万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
-
批准号:10205765
-
项目类别:
-
资助金额:$15.56万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
-
批准号:10608106
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
-
批准号:10063938
-
项目类别:
-
资助金额:$74.22万
-
财政年份:2017
-
负责人:Arash Grakoui
-
依托单位:
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
-
批准号:10305612
-
项目类别:
-
资助金额:$66.91万
-
财政年份:2017
-
负责人:Arash Grakoui
-
依托单位:
T cell compartmentalization and antiviral response
-
批准号:9127649
-
项目类别:
-
资助金额:$64.13万
-
财政年份:2016
-
负责人:Arash Grakoui
-
依托单位:
DEFINING THE INTRAHEPATIC IMMUNE RESPONSE TO HEPATITIS C VIRUS
-
批准号:8357563
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2011
-
负责人:Arash Grakoui
-
依托单位:
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE
-
批准号:8357445
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2011
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:8250010
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
UNDERSTANDING MECHANISMS OF HCV PERSISTENCE
-
批准号:8172414
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:7781668
-
项目类别:
-
资助金额:$43.72万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:8050079
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:8460497
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
IMMUNOLOGICAL STRATEGIES FOR CURING CHRONIC HEPATITIS VIRUS INFECTIONS
-
批准号:8172415
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
海外基金